Evidence map›Paper›PMID 28467822›Full record

ArticleNature2017

FGF-dependent metabolic control of vascular development.

Pengchun Yu, Kerstin Wilhelm, Alexandre Dubrac, Joe K Tung, Tiago C Alves, Jennifer S Fang, Yi Xie, Jie Zhu, Zehua Chen, Frederik De Smet and 12 more

Abstract read
In one paragraph

Article in Nature, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 204 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
204citing papers in PubMed, 1 pooled it
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

204 citing papers in PubMed, 1 synthesis or guideline pooled it, 372 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

144 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 5 countries.

Pengchun YuYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Kerstin Wilhelm *Angiogenesis & Metabolism Laboratory, Max Plank Institute for Heart and Lung Research, D-61231 Bad Nauheim, Germany.
Alexandre Dubrac *Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Joe K Tung *Yale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Tiago C AlvesSection of Endocrinology, Department of Internal Medicine, Yale University School of Medicine.
Jennifer S FangYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Yi XieYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Jie ZhuDepartment of Cellular and Molecular Physiology, Yale University School of Medicine.
Zehua ChenComputational Statistics and Bioinformatics Group, Advanced Artificial Intelligence Research Laboratory, WuXi NextCODE, Cambridge, MA, USA.
Frederik De SmetSwitch Laboratory, VIB-KU Leuven, Leuven, B-3000, Belgium.
Jiasheng ZhangYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Suk-Won JinYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Lele SunGenomics Laboratory, WuXi NextCODE, Shanghai, China.
Hongye SunGenomics Laboratory, WuXi NextCODE, Shanghai, China.
Richard G KibbeySection of Endocrinology, Department of Internal Medicine, Yale University School of Medicine.
Karen K HirschiYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Nissim HayDepartment of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago.
Peter CarmelietLaboratory of Angiogenesis and Neurovascular Link, Department of Oncology, University of Leuven, Leuven, B-3000, Belgium.
Thomas W ChittendenComputational Statistics and Bioinformatics Group, Advanced Artificial Intelligence Research Laboratory, WuXi NextCODE, Cambridge, MA, USA.
Anne EichmannYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Michael PotenteAngiogenesis & Metabolism Laboratory, Max Plank Institute for Heart and Lung Research, D-61231 Bad Nauheim, Germany.
Michael SimonsYale Cardiovascular Research Center, Yale University School of Medicine, New Haven, USA.
Yale University · USIntel (United States) · USKU Leuven · BEMax Planck Institute for Heart and Lung Research · DEGwangju Institute of Science and Technology · KRUniversity of Illinois Chicago · US

Funding

The Role of Akt in Cell Survival and Cell GrowthR01AG016927 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HAY, NISSIM · 1998 to 2023
$9.0M
Angiogensis and ischemiaR01HL053793 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 1996 to 2017
$7.3M
Tissue Chips for Rare Disease: Adding Timothy Syndrome to the HeLIVaSkCa platformUH3EB017103 · NIBIB · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI VUNJAK-NOVAKOVIC, GORDANA · 2014 to 2016
$7.1M
Arteriogenesis and BranchingR01HL084619 · NHLBI · YALE UNIVERSITY · PI SIMONS, MICHAEL · 2007 to 2018
$6.7M
Targeting endothelial migration to prevent neovascularizationR01HL125811 · NHLBI · YALE UNIVERSITY · PI EICHMANN, ANNE CHRISTINE · 2015 to 2025
$4.1M
Multi-tissue platform for modeling systemic pathologiesUG3EB025765 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI VUNJAK-NOVAKOVIC, GORDANA · 2017 to 2019
$2.8M
Hexokinase 2 in liver cancerR01CA206167 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HAY, NISSIM · 2016 to 2020
$2.1M
Chastening the double-edged sword of glucose metabolism in beta-cellsR01DK110181 · NIDDK · YALE UNIVERSITY · PI KIBBEY, RICHARD G · 2016 to 2019
$1.7M
European Research Council 311546NCI NIH HHS R01 CA206167NHLBI NIH HHS R01 HL053793NHLBI NIH HHS R01 HL084619NHLBI NIH HHS R01 HL125811NIA NIH HHS R01 AG016927NIBIB NIH HHS UG3 EB025765NIBIB NIH HHS UH3 EB017103NIDDK NIH HHS R01 DK110181
6 · The paper itself

Abstract

Blood and lymphatic vasculatures are intimately involved in tissue oxygenation and fluid homeostasis maintenance. Assembly of these vascular networks involves sprouting, migration and proliferation of endothelial cells. Recent studies have suggested that changes in cellular metabolism are important to these processes. Although much is known about vascular endothelial growth factor (VEGF)-dependent regulation of vascular development and metabolism, little is understood about the role of fibroblast growth factors (FGFs) in this context. Here we identify FGF receptor (FGFR) signalling as a critical regulator of vascular development. This is achieved by FGF-dependent control of c-MYC (MYC) expression that, in turn, regulates expression of the glycolytic enzyme hexokinase 2 (HK2). A decrease in HK2 levels in the absence of FGF signalling inputs results in decreased glycolysis, leading to impaired endothelial cell proliferation and migration. Pan-endothelial- and lymphatic-specific Hk2 knockouts phenocopy blood and/or lymphatic vascular defects seen in Fgfr1/Fgfr3 double mutant mice, while HK2 overexpression partly rescues the defects caused by suppression of FGF signalling. Thus, FGF-dependent regulation of endothelial glycolysis is a pivotal process in developmental and adult vascular growth and development.

Indexed as

GlycolysisNeovascularization, PhysiologicSignal TransductionAnimalsCell MovementCell ProliferationEndothelial CellsFemaleFibroblast Growth FactorsHexokinaseLymphangiogenesisLymphatic VesselsMiceMice, Inbred C57BLProto-Oncogene Proteins c-mycReceptor, Fibroblast Growth Factor, Type 1Fgfr1 protein, mouseFgfr3 protein, mouseFibroblast Growth FactorsHexokinasehexokinase 2, mouseMyc protein, mouseProto-Oncogene Proteins c-mycReceptor, Fibroblast Growth Factor, Type 1Receptor, Fibroblast Growth Factor, Type 3

Identifiers

PMID28467822
PMCPMC5427179
OpenAlexW2610643018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.